Infinity gets $75M for cancer partnership

Published on Friday 21 November 2008 - 15:19

Summary :
Infinity Pharmaceuticals is getting $75 million up-front in a partnership deal for the company's early-stage research. Purdue Pharma and affiliate Mundipharma are buying 4 million shares of...
Read more

Information source

http://www.fiercebiotech.com/news/frontpage

Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry

Articles published on this website : 1 / 7 days - 4 / 30 days

FDA approves prostate cancer drug Degarelix Amgen files for crucial denosumab approval Synta gets $15M milestone from GSK AZ returns rights to two oncology programs OncoGenex shares soar on promising prostate cancer data

Other articles published on other websites on the same day

Crisis In The Lab: Biotech Bankruptcies Are Looming http://www.pharmalot.com/ Another Thing Candidates Can Run On: Genetic Profile http://www.sci-tech-today.com/ Surprising links between prostate and breast cancer http://3news.co.nz/ World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH) http://www.prweb.com/ Doctor: Leaders must have health exams http://www.timesoftheinternet.com/ Mechanisms of cardiovascular disease and cancer give clues to new therapies http://www.eurekalert.org/ Soy Isoflavones Linked to Reduced Prostate Cancer Risk http://www.modernmedicine.com/ Obituary: Activist, Spanish newspaper director 'was always for the underdog' http://www.palmbeachpost.com/ Amgen Halts Phase III Trials Of Lung Cancer Drug http://www.injuryboard.com/ Targeted nanoparticles boost platinum-based anticancer therapy http://www.news-medical.net/